These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7321760)
21. Neurochemical changes following kainic acid lesions of the nucleus accumbens: implications for a GABAergic accumbal-ventral tegmental pathway. Waddington JL; Cross AJ Life Sci; 1978 Mar; 22(11):1011-4. PubMed ID: 25363 [No Abstract] [Full Text] [Related]
22. Inhibitors of GABA metabolism: implications for Huntington's disease. Schwarcz R; Bennett JP; Coyle JT Ann Neurol; 1977 Oct; 2(4):299-303. PubMed ID: 152600 [TBL] [Abstract][Full Text] [Related]
23. GABA-receptors in the substantia nigra controlling cyclic-GMP in the cerebellar cortex. Biggio G; Corda MG; Casu M; Mulas ML; Gessa GL Adv Exp Med Biol; 1979; 123():419-27. PubMed ID: 229716 [No Abstract] [Full Text] [Related]
24. Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: the GABA connection. Nagy JI; Carter DA; Fibiger HC Brain Res; 1978 Dec; 158(1):15-29. PubMed ID: 21348349 [TBL] [Abstract][Full Text] [Related]
25. Release of gamma-[3H]aminobutyric acid from rat olfactory bulb and substantia nigra: differential modulation by glutamic acid. Jaffé EH; Vaello ML J Neurochem; 1989 Jun; 52(6):1766-74. PubMed ID: 2566648 [TBL] [Abstract][Full Text] [Related]
26. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA. Hill JM Brain Res; 1985 Sep; 342(1):18-25. PubMed ID: 4041811 [TBL] [Abstract][Full Text] [Related]
27. GABA-ergic system in brain regions of glutamate-lesioned rats. Di Giorgio RM; De Luca GC; Garofalo MP; Conti C; Ientile R Ital J Biochem; 1985; 34(1):19-28. PubMed ID: 4008230 [TBL] [Abstract][Full Text] [Related]
28. Effect of the normal nerve impulse flow on the synthesis and utilization of GABA in the rat substantia nigra. Lindgren S; Andén NE J Neural Transm; 1985; 61(1-2):21-34. PubMed ID: 3981161 [TBL] [Abstract][Full Text] [Related]
29. Gamma-aminobutyric acid turnover in rat striatum: effects of glutamate and kainic acid. Giorgi O; Meek JL J Neurochem; 1984 Jan; 42(1):215-20. PubMed ID: 6139420 [TBL] [Abstract][Full Text] [Related]
30. Neuronal responses to iontophoretically applied dopamine, glutamate, and GABA of identified dopaminergic cells in the rat substantia nigra after kainic acid-induced destruction of the striatum. Scarnati E; Pacitti C Exp Brain Res; 1982; 46(3):377-82. PubMed ID: 6124446 [TBL] [Abstract][Full Text] [Related]
31. Distribution and release of GABA in the basal ganglia. Korf J; van der Heyden JA; Venema K; Postema F Adv Biochem Psychopharmacol; 1981; 30():105-17. PubMed ID: 7331934 [No Abstract] [Full Text] [Related]
32. [Toxic action of kainic acid as a model of Huntington chorea and epilepsy (review)]. Levin SL; Sytinskiĭ IA Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):754-63. PubMed ID: 6224382 [No Abstract] [Full Text] [Related]
33. GABAergic denervation of rat substantia nigra: functional and pharmacological properties. Gale K; Iadarola MJ Brain Res; 1980 Feb; 183(1):217-23. PubMed ID: 6244049 [No Abstract] [Full Text] [Related]
34. The histochemical localization of GABA-transaminase in the efferents of the striatum. Vincent SR; Kimura H; McGeer EG Brain Res; 1981 Oct; 222(1):198-203. PubMed ID: 7296268 [TBL] [Abstract][Full Text] [Related]
35. Inhibitory mechanisms in the substantia nigra and the dopamine pathway. Straughan DW; James TA Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391 [No Abstract] [Full Text] [Related]
36. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system]. Zharkovskiĭ AM; Nurk AM Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331 [TBL] [Abstract][Full Text] [Related]
37. Changes in gamma-aminobutyrate, glutamate, aspartate, glycine, and taurine contents in the striatum after unilateral nigrostriatal lesions in rats. Tanaka Y; Niijima K; Mizuno Y; Yoshida M Exp Neurol; 1986 Feb; 91(2):259-68. PubMed ID: 2867926 [TBL] [Abstract][Full Text] [Related]
38. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata. Löscher W; Hönack D; Bloms-Funke P Brain Res; 1996 Oct; 735(2):208-16. PubMed ID: 8911659 [TBL] [Abstract][Full Text] [Related]
39. Striatonigral and pallidonigral pathways studied by a combination of retrograde horseradish peroxidase tracing and a pharmacohistochemical method for gamma-aminobutyric acid transaminase. Araki M; McGeer PL; McGeer EG Brain Res; 1985 Apr; 331(1):17-24. PubMed ID: 3986561 [TBL] [Abstract][Full Text] [Related]
40. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons. Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]